TWIST overexpression predicts biochemical recurrence-free survival in prostate cancer patients treated with radical prostatectomy
Sami RaatikainenS. AaltomaaJorma J. PalvimoVesa KärjäYlermi Soini
Abstract
M-TWIST overexpression is associated with clinicopathological prognosis factors and M-AR overexpression and is a powerful independent predictor of BFS in conjunction with the Gleason score in prostate cancer patients treated with RP.
Metrics
Citation History
Topics
Related Documents
Aberrant Methylation of PCDH10 Predicts Worse Biochemical Recurrence-Free Survival in Patients with Prostate Cancer After Radical Prostatectomy
352 Prostate health index predicts biochemical recurrence in patients with organ-confined prostate cancer treated with radical prostatectomy
Giovanni LughezzaniMassimo LazzeriAlberto AbrateElla KinzikeevaFrancesco Alessandro MistrettaNicolò Maria BuffiGiuliana ListaAlessandro LarcherNicola FossatiGiulio Maria GaddaPaolo Dell’OglioGiorgio Guazzoni
Conditional biochemical recurrence-free survival after radical prostatectomy in patients with high-risk prostate cancer
Sung‐Woo ParkDae Sung HwangWon Hoon SongJong Kil NamHyun Jung LeeMoon Kee Chung
A Novel Gene Signature-Based Model Predicts Biochemical Recurrence-Free Survival in Prostate Cancer Patients after Radical Prostatectomy
Run ShiXuanwen BaoJoachim WeischenfeldtChristian SchaeferPaul RogowskiNina-Sophie Schmidt-HegemannKristian UngerKirsten LauberXuanbin WangAlexander BüchnerChristian G. StiefThorsten SchlommClaus BelkaMinglun Li
RHCG and TCAF1 promoter hypermethylation predicts biochemical recurrence in prostate cancer patients treated by radical prostatectomy
Siri H. StrandMichał ŚwitnickiMia MøllerChrista HaldrupTine M. StorebjergJakob HedegaardIver NordentoftS. HøyerMichael BorreJakob Skou PedersenPeter J. WildJong Y. ParkTorben F. ØrntoftKarina D. Sørensen